Petrylak DP, Balar AV, O'Donnell PH, et al. EV-201: Results of enfortumab vedotin monotherapy for locally advanced or metastatic urothelial cancer previously treated with platinum and immune checkpoint inhibitors. ASCO Annual Meeting 2019, abstract LBA4505.
Lenvatinib plus pembrolizumab bij gevorderd melanoom met ziekteprogressie
aug 2022 | Dermato-oncologie